Abt Global has won a spot on the Centers for Medicare and Medicaid Services’ Research, Measurement, Assessment, Design and Analysis 3 contract vehicle, known as RMADA 3. It’s the third consecutive award for Abt.
Under RMADA 3, Abt will support CMS and the Center for Medicare and Medicaid Innovation in designing, implementing, evaluating and communicating evidence-based approaches to improve healthcare quality, strengthen program performance and reduce costs. Its work includes Medicare payment systems, alternative payment models, data analytics, implementation support and communications.
“Winning a seat on RMADA 3 reflects the trust CMS has placed in Abt to bring rigorous evidence, practical implementation experience, and innovation to complex healthcare challenges,” said ZeAmma Brathwaite, vice president of U.S. domestic healthcare at Abt Global. “We understand where CMMI has been and how to help CMS move quickly as its priorities evolve—delivering actionable insights and solutions that support better outcomes for the people CMS serves.”
Abt said its prior RMADA work helped CMS streamline model implementation, improve data use and communicate results to policymakers, stakeholders and the public. The company will continue providing research, analytics, digital, technical assistance and communications support.